Takeda Pharmaceutical Co., Ltd.
Takeda Pharmaceutical Co., Ltd./ JP3463000004 /
TKPHF
|
07/11/2024 15:30:00
|
Chg.
-1.8400
|
Volume |
Bid- |
Demandez à- |
Capitalisation boursière |
Dividende Y. |
Rapport P/E |
|
26.7600USD
|
-6.43%
|
119,689
Chiffrre d'affaires: 7,599.8400 |
-Bid taille: - |
-Ask la taille: - |
43.47 Mrd.USD |
- |
- |
Description de l'entreprise
Located in Osaka, Japan, Takeda (TYO: 4502) is a research-based global company with its main focus on pharmaceuticals. As the largest pharmaceutical company in Japan and one of the global leaders of the industry, Takeda is committed to strive towards better health for people worldwide through leading innovation in medicine.
Conseil d'administration & Conseil de surveillance
| PDG |
| Christophe Weber |
| Conseil d'administration |
| Costa Saroukos, Akiko Amakawa, Elaine Shannon, Gabriele Ricci, Giles Platford, Julie Kim, Lauren Duprey, Marcello Agosti, Milano Furuta, Mwana Lugogo, Ramona Sequeira, Takako Ohyabu, Teresa Bitetti, Thomas Wozniewski, Yoshihiro Nakagawa |
| Conseil de surveillance |
| Christophe Weber, Costa Saroukos, Dr. Andrew Plump, Emiko Higashi, Ian Clark, Jean-Luc Butel, Koji Hatsukawa, Michel Orsinger, Olivier Bohuon, Yoshiaki Fujimori, Masami Iijima, Steven Gillis, John Maraganore, Miki Tsusaka, Kimberly A. Reed |
Données de l'entreprise
| Nom: |
Takeda Pharmaceutical Company Ltd. |
| Adresse: |
1-1, Nihonbashi-Honcho 2-Chome,Chuo-ku, Tokyo 103-8668, Japan |
| Téléphone: |
+81-3-3278-2306 |
| Fax: |
+81-3-3278-2268 |
| Courriel: |
-
|
| Internet: |
www.takeda.com/ |
| Industrie: |
Healthcare |
| Secteur: |
Pharmaceutical Industry |
| Sous-secteur: |
Pharmaceuticals |
| Fin de l'exercice financier: |
31/03 |
| Flotte libre: |
- |
| IPO date: |
- |
Relations avec les investisseurs
| Nom: |
Christopher O'Reilly |
| Téléphone IR: |
+81-3-3278-2037 |
| IR-Fax: |
+81-3-3278-2741 |
| E-mail IR: |
takeda.ir.contact@takeda.com
|
